Xenogeneic transplantation of porcine islets: an overview
Cardiac allograft vasculopathy: central role of endothelial injury leading to transplant “atheroma”
Heterozygous disruption of the α1,3-galactosyltransferase gene in cattle
Clinical outcomes during the first three months posttransplant in renal allograft recipients managed by C2 monitoring of cyclosporine microemulsion
Protocol Biopsy of the Stable Renal Transplant: A Multicenter Study of Methods and Complication Rates. Transplantation 2003; 76: 969. P. N. Furness, C. M. Philpott, M. T. Chorbadjian, M. L. Nicholson, J.-L. Bosmans, B. L. Corthouts, J. J. P. M. Bogers, A. Schwarz, W. Gwinner, H. Haller, M. Mengel, D. Seron, F. Moreso, C. Cañas
Preserving the mucosal barrier during small bowel storage1
Chronic rejection: the next major challenge for pancreas transplant recipients
Impaired insulin response after oral but not intravenous glucose in heart- and liver-transplant recipients
Primary brain lymphomas after kidney transplantation: presentation and outcome
Withdrawal of steroid therapy in African American kidney transplant recipients receiving sirolimus and tacrolimus.1
Outcomes for pediatric liver retransplantation from living donors
Shortage of donation despite an adequate number of donors: a professional attitude?
Computer-assisted quantification of fibrosis in chronic allograft nephropaty by picosirius red-staining: a new tool for predicting long-term graft function1
Tumor origin and CD20 expression in posttransplant lymphoproliferative disorder occurring in solid organ transplant recipients: implications for immune-based therapy.1
Incidence of clinically unsuspected pulmonary embolism in mechanically ventilated lung transplant recipients
Protocol biopsy of the stable renal transplant: a multicenter study of methods and complication rates
Pancreas transplant alone determines early improvement of cardiovascular risk factors and cardiac function in type 1 diabetic patients1
Efficacy and safety of itraconazole prophylaxis for fungal infections after orthotopic liver transplantation: a prospective, randomized, double-blind study
Is posttransplant lymphoproliferative disorder (PTLD) caused by any specific immunosuppressive drug or by the transplantation per se?
Long-term acceptance of composite tissue allografts through mixed chimerism and CD28 blockade
Stimulating PD-1–negative signals concurrent with blocking CD154 co-stimulation induces long-term islet allograft survival1
Gadolinium-enhanced three-dimensional magnetic resonance angiography versus conventional digital subtraction angiography: which modality is superior in evaluating living kidney donors?1
Living donor liver transplantation and tolerance: a potential strategy in cholangiocarcinoma.
LIFE-THREATENING VENO-OCCLUSIVE DISEASE AFTER LIVING-RELATED LIVER TRANSPLANTATION
PREFERRED METHOD FOR INTRAVENOUS ADMINISTRATION OF RABBIT ANTITHYMOCYTE GLOBULIN
TRANSPLANTATION
INSURANCE ISSUES IN LIVING KIDNEY DONATION
ERRATUM